Suchergebnisse - "Zhang, Yuntao"

PubPharm (33)

21

Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults

enthalten in: Frontiers of medicine | 2022

von Zhang, Y. | Yang, Y. | Qiao, N. | +8

22

Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults

enthalten in: Frontiers of medicine | 2022

von Zhang, Y. | Yang, Y. | Qiao, N. | +8

23

Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults

enthalten in: Frontiers of medicine | 2022

von Zhang, Y. | Yang, Y. | Qiao, N. | +8

24

Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults

enthalten in: Frontiers of medicine in China | 2022

von Zhang, Y. | Yang, Y. | Qiao, N. | +8

25

A Pre-Generation of Emergency Reference Plan Model of Public Health Emergencies with Case-Based Reasoning

enthalten in: Risk management and healthcare policy | 2022

von Ru, D. | Wen, H. | Zhang, Y.

26

Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children : Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial

enthalten in: Frontiers in immunology | 2022

von Xia, S. | Duan, K. | Zhang, Y. | +35

27

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years : a randomised, double-blind, controlled, phase 1/2 trial

enthalten in: The Lancet. Infectious diseases | 2022

von Xia, S. | Zhang, Y. | Wang, Y. | +35

28

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older : A randomized, double-blind, placebo-controlled, phase 1/2 trial

enthalten in: EClinicalMedicine | 2021

von Guo, W. | Duan, K. | Zhang, Y. | +35

29

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults : A Randomized Clinical Trial

enthalten in: JAMA | 2021

von Al Kaabi, N. | Zhang, Y. | Xia, S. | +38

30

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV : a randomised, double-blind, placebo-controlled, phase 1/2 trial

enthalten in: The Lancet. Infectious diseases | 2021

von Xia, S. | Zhang, Y. | Wang, Y. | +29